Search

Search Results

• Primary Immune Thrombocytopenia and Thrombopoietin Receptor Agonists: Feasibilities of Treatment Discontinuation upon Achieving Stable Complete Platelet Response

  O.Yu. Vinogradova, M.M. Pankrashkina, Anna Leonidovna Neverova, M.V. Chernikov, L.A. Mukha, D.I. Shikhbabaeva, V.V. Ptushkin

  413-425

  28.09.2023

• Quality of Life Changes in Patients with Chronic Immune Thrombocytopenia in the Process of Romiplostim Therapy, its Efficacy and Safety in the Real-World Setting: Results of a Multi-Center Observational Study

  T.I. Ionova, O.Yu. Vinogradova, T.V. Shelekhova, D.G. Sherstnev, A.V. Proidakov, E.V. Lyyurova, M.M. Pankrashkina, L.A. Mukha, E.E. Markova, N.V. Novitskaya, T.I. Pospelova, T.N. Babaeva, N.B. Bulieva, G.B. Kuchma, E.A. Andreevskaya, E.E. Zinina, M.V. Frolova, K.B. Trizna, I.L. Shestopalova, T.V. Shneider, S.A. Volkova, S.G. Zakharov, I.I. Mulina, I.E. Solov’eva, A.A. Myasnikov, A.A. Kuchin, L.B. Khvorostenko, N.M. Porfirieva, Tatyana Pavlovna Nikitina, V.V. Ptushkin, S.V. Gritsaev

  154-165

  03.03.2023

• Pharmacoeconomic Analysis of the Use of Thrombopoietin Receptors Agonists in Idiopathic Thrombocytopenic Purpura Therapy

  Vasilii Anatol’evich Shuvaev, S.V. Voloshin, A.K. Hadzhidis, A.V. Chechetkin

  435-442

  01.10.2017

• Thrombopoietin Receptor Agonists in Treatment of Idiopathic Thrompocytopenic Purpura (Primary Immune Thrombocytopenia): Efficacy and Safety in Everyday Clinical Practice

  Irina Ivanovna Zotova, S.V. Gritsaev, E.R. Shilova, N.A. Potikhonova, K.М. Abdulkadyrov, A.V. Chechetkin

  93-100

  01.01.2017